These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1394662)

  • 1. Agents for the treatment of overactive detrusor. III. Synthesis and structure-activity relationships of N-(4-amino-2-butynyl)acetamide derivatives.
    Take K; Okumura K; Tsubaki K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1415-23. PubMed ID: 1394662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agents for the treatment of overactive detrusor. VI. Synthesis and pharmacological properties of acetamide derivatives bearing cyclic amines in N-substituents.
    Taniguchi K; Tsubaki K; Mizuno H; Take K; Okumura K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1994 Jan; 42(1):74-84. PubMed ID: 8124770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogues of oxybutynin. Synthesis and antimuscarinic and bladder activity of some substituted 7-amino-1-hydroxy-5-heptyn-2-ones and related compounds.
    Carter JP; Noronha-Blob L; Audia VH; Dupont AC; McPherson DW; Natalie KJ; Rzeszotarski WJ; Spagnuolo CJ; Waid PP; Kaiser C
    J Med Chem; 1991 Oct; 34(10):3065-74. PubMed ID: 1920357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 4-ethylamino-2-butynyl(2-cyclohexyl-2-phenyl)glycolate hydrochloride, a metabolite of oxybutynin, on bladder specimens and rhythmic bladder contraction in rats in comparison with oxybutynin.
    Uchida M; Koganei M; Murata N; Yamaji T
    J Pharmacol Sci; 2004 Feb; 94(2):122-8. PubMed ID: 14978349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents for the treatment of overactive detrusor. VII. Synthesis and pharmacological properties of 2,3- and 3,4-diphenylcyclopentylamines, 2,3-diphenyl-2-cyclopentenylamines, and related compounds.
    Taniguchi K; Tsubaki K; Take K; Okumura K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):896-902. PubMed ID: 8020125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agents for the treatment of overactive detrusor. I. Synthesis and structure-activity relationships of 1,1'-biphenyl derivatives.
    Take K; Okumura K; Takimoto K; Kato M; Ohtsuka M; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2915-23. PubMed ID: 1799939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of 4-ethylamino-2-butynyl(2-cyclohexyl-2-phenyl) glycolate, metabolite of oxybutynin, on intra-artery administered acetylcholine-induced urinary bladder contraction in anesthetized dogs].
    Uchida M; Nakajima M; Koganei M; Yamaji T
    Nihon Yakurigaku Zasshi; 2004 May; 123(5):363-71. PubMed ID: 15118260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agents for the treatment of overactive detrusor. IV. Synthesis and structure-activity relationships of cyclic analogues of terodiline.
    Take K; Okumura K; Tsubaki K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):507-15. PubMed ID: 8477501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oxyphenonium bromide and oxybutynin hydrochloride on detrusor contractility and reflux in children with vesicoureteral reflux and detrusor instability.
    Scholtmeijer RJ; van Mastrigt R
    J Urol; 1991 Aug; 146(2 ( Pt 2)):660-2. PubMed ID: 1907331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agents for the treatment of overactive detrusor. VIII. Synthesis and pharmacological properties of 4,4-diphenyl-2-cycloalkenylamines including FK584 and 3,3- or 4,4-diphenylcycloalkylamines.
    Taniguchi K; Okumura K; Take K; Tsubaki K; Terai T; Nakanishi I; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):71-7. PubMed ID: 7895309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agents for the treatment of overactive detrusor. II. Synthesis and inhibitory activity on detrusor contraction of 1,1'-biphenyl-2,6-dicarboxylic acid diesters with an aminoalkyl group in the ester function.
    Take K; Okumura K; Takimoto K; Ohtsuka M; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):899-906. PubMed ID: 1525946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological effects of tolterodine on human isolated urinary bladder.
    Yono M; Yoshida M; Wada Y; Kikukawa H; Takahashi W; Inadome A; Seshita H; Ueda S
    Eur J Pharmacol; 1999 Mar; 368(2-3):223-30. PubMed ID: 10193658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.
    Yarker YE; Goa KL; Fitton A
    Drugs Aging; 1995 Mar; 6(3):243-62. PubMed ID: 7620236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bryophyllum pinnatum inhibits detrusor contractility in porcine bladder strips--a pharmacological study towards a new treatment option of overactive bladder.
    Schuler V; Suter K; Fürer K; Eberli D; Horst M; Betschart C; Brenneisen R; Hamburger M; Mennet M; Schnelle M; Simões-Wüst AP; von Mandach U
    Phytomedicine; 2012 Jul; 19(10):947-51. PubMed ID: 22824522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different responses to drugs against overactive bladder in detrusor muscle of pig, guinea pig and mouse.
    Wüst M; Averbeck B; Reif S; Bräter M; Ravens U
    Eur J Pharmacol; 2002 Nov; 454(1):59-69. PubMed ID: 12409006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro effects of imipramine, oxybutynin, and flavoxate on rabbit detrusor.
    Fredericks CM; Green RL; Anderson GF
    Urology; 1978 Oct; 12(4):487-91. PubMed ID: 568842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the oxybutynin antagonism of drug-induced spasms in detrusor.
    Anderson GF; Fredericks CM
    Pharmacology; 1977; 15(1):31-9. PubMed ID: 190623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of oxybutynin on lower urinary tract function].
    Nishizawa O; Sugaya K; Suzuki T; Kohama T; Matsuzaki A; Fukuda T; Harada T; Tsuchida S
    Hinyokika Kiyo; 1988 Aug; 34(8):1383-7. PubMed ID: 3195406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effects of oxybutynin hydrochloride in the treatment of unstable bladder and overactive neurogenic bladder: a long-term clinical trial].
    Goto M; Kato K; Kondo A; Otani T; Takita T; Kobayashi M
    Hinyokika Kiyo; 1988 Mar; 34(3):541-50. PubMed ID: 3389295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.